The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia
Article in Journal of Medical Economics (July 2022)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Journal of Medical Economics (July 2022)
Article in Farmatsevtychnyĭ Zhurnal (December 2021)
Article in Neurología (English Edition) (November 2021)